MarketCap
Facebook
X
Telegram
Ampio Pharmaceuticals Gesamtverbindlichkeiten | AMPE
Gesamtverbindlichkeiten Jährlich Ampio Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.38 M | 1.8 M | 11.5 M | 5.37 M | 7.56 M | 8.79 M | 49.5 M | 6.96 M | 12.5 M | 4.81 M | 2.8 M | 2.02 M | 1.72 M | 4.75 M | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 49.5 M | 1.72 M | 8.75 M |
Gesamtverbindlichkeiten Vierteljährlich Ampio Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.27 M | 2.59 M | 2.86 M | 1.8 M | 4.99 M | 7.12 M | 10.5 M | 11.5 M | 5.2 M | 6.35 M | 4.95 M | 5.37 M | 4.82 M | 5.52 M | 6.85 M | 7.56 M | 11.8 M | 9.78 M | 13.1 M | 8.79 M | 13.3 M | 15.4 M | 23.5 M | 49.5 M | 9.59 M | 9.33 M | 5.82 M | 6.96 M | 7.05 M | 3.22 M | 3.93 M | 12.5 M | 10.6 M | 4.61 M | 3.31 M | 4.81 M | 4.27 M | 5.07 M | 5.39 M | 2.8 M | 2.43 M | 2.79 M | 2.09 M | 2.02 M | 1.69 M | 1.5 M | 1.33 M | 1.72 M | 2.14 M | 2.38 M | 1.72 M |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 49.5 M | 1.33 M | 6.99 M |
Gesamtverbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Eyenovia
EYEN
|
10.7 M | - | 49.81 % | $ 13.2 M |  USA |
 |
FibroGen
FGEN
|
115 M | - | - | $ 889 M | USA |
 |
Homology Medicines
FIXX
|
19.8 M | - | 0.77 % | $ 53.4 M | USA |
 |
Amicus Therapeutics
FOLD
|
676 M | - | - | $ 4.47 B | USA |
 |
Frequency Therapeutics
FREQ
|
62.1 M | - | - | $ 528 M | USA |
|
Galecto
GLTO
|
20.1 M | - | - | $ 762 M |  Danmark |
 |
GlycoMimetics
GLYC
|
37.3 M | - | 9357.83 % | $ 1.01 B | USA |
 |
Graybug Vision
GRAY
|
20.2 M | - | -11.23 % | $ 9.65 M | USA |
|
Galera Therapeutics
GRTX
|
645 K | - | -32.59 % | $ 7.61 M | USA |
 |
Happiness Biotech Group Limited
HAPP
|
3.86 M | - | 1.35 % | $ 17.8 M |  China |
 |
Novavax
NVAX
|
1.3 B | $ 10.15 | -6.8 % | $ 1.64 B | USA |
 |
Hepion Pharmaceuticals
HEPA
|
402 K | - | -18.79 % | $ 39.3 K | USA |
 |
Hoth Therapeutics
HOTH
|
1.45 M | - | - | $ 18.8 M | USA |
 |
IMARA
IMRA
|
16.6 M | - | 15.96 % | $ 663 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
338 M | - | - | $ 1.45 B |  Britain |
 |
KemPharm
KMPH
|
130 M | - | -0.34 % | $ 200 M | USA |
 |
Kezar Life Sciences
KZR
|
6.57 M | - | - | $ 53.3 M | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
1.77 M | - | - | $ 63.4 M | USA |
 |
Magenta Therapeutics
MGTA
|
37.5 M | - | -7.74 % | $ 41.6 M | USA |
 |
NovaBay Pharmaceuticals
NBY
|
640 M | - | - | $ 11.3 M | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
5.79 M | - | 0.43 % | $ 12 M | USA |
 |
OncoCyte Corporation
OCX
|
57.2 M | - | 17.22 % | $ 355 K | USA |
 |
Onconova Therapeutics
ONTX
|
11.2 M | - | -0.47 % | $ 21 M | USA |
 |
Opthea Limited
OPT
|
258 M | - | - | $ 1.2 B |  Australia |
 |
Verastem
VSTM
|
189 M | $ 8.74 | 0.52 % | $ 606 M | USA |
|
BiomX
PHGE
|
12.9 M | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
31.6 M | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
12.3 M | - | - | $ 301 M | USA |
 |
Pluristem Therapeutics
PSTI
|
9.43 M | - | -1.9 % | $ 33.3 M | Israel |
 |
Qualigen Therapeutics
QLGN
|
4.14 M | - | 5.59 % | $ 1.16 M | USA |
|
Qilian International Holding Group Limited
QLI
|
41.9 M | - | -6.08 % | $ 184 M | China |
 |
Cassava Sciences
SAVA
|
44 M | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
423 M | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
74 M | - | - | $ 50.4 M | USA |
 |
Salarius Pharmaceuticals
SLRX
|
5.17 M | - | - | $ 2.64 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
4.31 M | - | - | $ 17.5 M | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
4.1 M | - | - | $ 826 K | USA |
 |
Synthetic Biologics
SYN
|
22.9 M | - | 1.32 % | $ 16.2 M | USA |
 |
Synlogic
SYBX
|
28.7 M | - | - | $ 7.07 M | USA |
 |
Virios Therapeutics, LLC
VIRI
|
15.3 M | - | 2710.01 % | $ 72.9 M | USA |
 |
Vallon Pharmaceuticals
VLON
|
2.66 M | - | -6.47 % | $ 5.76 M | USA |
 |
Vaxart
VXRT
|
85.9 M | - | -25.06 % | $ 46.3 M | USA |
 |
XOMA Corporation
XOMA
|
169 M | - | - | $ 485 M | USA |
 |
Repare Therapeutics
RPTX
|
25.4 M | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
58.4 M | - | 7.29 % | $ 127 M | USA |
|
Windtree Therapeutics
WINT
|
14.7 M | - | - | $ 26.8 M | USA |
 |
Trean Insurance Group
TIG
|
1.27 B | - | - | $ 316 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
42.8 M | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
1.07 M | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
1.84 M | - | - | $ 13 M | USA |